The synthetic biology concept bottomed out and Ruifeng Hi-Tech rose more than 15%. Previously, Blue Biotech went out of the 6-game market, with Yiqiao Shenzhou, Coastal Protein, Xinghu Technology, and Lukang Pharmaceutical leading the way. According to the CITIC Construction Investment Research Report, synthetic biology is a Chaoyang industry that emerged at the beginning of this century. It can transform and even create living systems. Currently, primary market financing is hot. Technological breakthroughs often spiral upward, and we should remain optimistic about the future development of the industry.
合成生物概念探底回升 瑞丰高材涨超15%
The synthetic biology concept rebounded and Ruifeng High Materials rose more than 15%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.